Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07126496

A Virtual Community Health Educator for Increasing Clinical Trial Referrals Among Cancer Patients and Their Caregivers

This clinical trial studies how well a virtual community health educator (vCHE) works in increasing clinical trial referrals for patients with cancer and their caregivers. Low enrollment of underrepresented and underserved populations in cancer clinical trials has led to disparities in intervention development and implementation. One approach to recruiting diverse populations to cancer clinical trials is community health educators. However, community health educator interventions are costly and difficult to implement. vCHEs are photo-realistic virtual agents that provide personalized guidance and support to users. They are designed to mimic real-life community health workers, offering culturally and linguistically tailored information to users. They can communicate in English or Spanish and are available in diverse genders and racial/ethnic backgrounds. vCHEs may be able to increase the enrollment of diverse participants into cancer clinical trials.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Hematopoietic and Lymphatic System Neoplasm Malignant Solid Neoplasm

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Individuals Diagnosed with Cancer
  • 18 years or older
  • Must have received a cancer diagnosis at any point in your life
  • Able to understand English or Spanish
  • Care Partners
  • Must be a care partner (also known as caregiver, carer, supporter, helper, aide, assistant, companion, attendant, advocate, or family caregiver) of an adult who has received a cancer diagnosis
  • Must be actively involved in the decision-making process OR care of a person diagnosed with cancer
  • Must be 18 years or older

Exclusion criteria

  • Self-reported: people who are currently or have been in a cancer clinical trial within the last 3 years

Treatment and study plan

Internet-Based Intervention

Other

Receive information via online text

Questionnaire Administration

Other

Ancillary studies

Virtual Technology Intervention

Other

Receive information via ALEX Research Portal and vCHE

Other names: Virtual Reality Intervention, Virtual Technology

Primary outcomes

  1. Proportion of referrals to cancer clinical trials (CCTs)

    Time frame: Up to 3 months

    Assessed by the number of referrals (patient self-referral or care partner referral) to an open cancer clinical trial (CCT).

  2. Number of patient referrals sent by a healthcare provider by using the ALEX portal

    Time frame: Up to 3 months

    Assessed by the number of referral sent by providers on a patient's behalf to a study coordinator for screening.

Study contacts

Contact information is provided by the study sponsor or research team.

Clinical Trials Referral Office

CONTACT

[email protected]

855-776-0015

Enhancing Technology & Communication in Healthcare (ETCH) Lab

CONTACT

[email protected]

904-953-5375

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Official study title

Precision Clinical Trial Recruitment to Promote Cancer Health Equity Across Florida (Aims 2 & 3)

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Aug 17, 2025
Registry last updated
Feb 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.